Your browser doesn't support javascript.
loading
Projecting the long-term economic benefits of reducing Shigella-attributable linear growth faltering with a potential vaccine: a modelling study.
Puett, Chloe; Anderson, John D; Bagamian, Karoun H; Muhib, Farzana; Scheele, Suzanne; Hausdorff, William P; Pecenka, Clint.
Afiliação
  • Puett C; Department of Family, Population & Preventive Medicine, Program in Public Health, Health Sciences Center, Stony Brook University, Stony Brook, NY, USA. Electronic address: chloe.puett@stonybrook.edu.
  • Anderson JD; Bagamian Scientific Consulting, Gainesville, FL, USA.
  • Bagamian KH; Bagamian Scientific Consulting, Gainesville, FL, USA; Department of Environmental and Global Health, University of Florida, Gainesville, FL, USA.
  • Muhib F; PATH, Washington, DC, USA.
  • Scheele S; PATH, Washington, DC, USA.
  • Hausdorff WP; PATH, Washington, DC, USA; Faculty of Medicine, Université Libre de Bruxelles, Brussels, Belgium.
  • Pecenka C; PATH, Seattle, WA, USA.
Lancet Glob Health ; 11(6): e892-e902, 2023 06.
Article em En | MEDLINE | ID: mdl-37202024
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Shigella / Vacinas Tipo de estudo: Health_economic_evaluation / Prognostic_studies Limite: Child / Humans Idioma: En Revista: Lancet Glob Health Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Shigella / Vacinas Tipo de estudo: Health_economic_evaluation / Prognostic_studies Limite: Child / Humans Idioma: En Revista: Lancet Glob Health Ano de publicação: 2023 Tipo de documento: Article